Sign in
Home
Biz News
New Products
Cell Therapy
Medical Devices
Journal Papers
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Friday, April 20, 2018
Sign in / Join
Contact
About
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Cell Tribune: Cell and Gene Therapy News
Home
Biz News
Abeona Receives FDA Regenerative Medicine Advanced Therapy Designation for EB-101 Gene Therapy in Epidermolysis Bullosa
CAR-T cell therapy benefits limited to few patients because of ‘Insurance Snags’
GenCure Opens BioManufacturing Center for Large-Scale Production of Adult Stem Cells to Support Development of New Cellular Therapies
Dynamk Capital Invests in FloDesign Sonics, a Game-Changer for Cell Therapy
Eutilex and Huahai Enter Immuno-Oncology Strategic Partnership Paving New Momentum into T Cell Therapy Programs
New Products
CAR-T cell therapy benefits limited to few patients because of ‘Insurance Snags’
Helix BioPharma Corp. announces the signing of a non-binding letter of intent with ProMab Biotechnologies to develop cell based therapies
Cell Therapy
Abeona Receives FDA Regenerative Medicine Advanced Therapy Designation for EB-101 Gene Therapy in Epidermolysis Bullosa
‘Decorated’ Stem Cells Could Offer Targeted Heart Repair
FDA Clears Pluristem’s Expanded Access Program to Initiate Treatments of Critical Limb Ischemia Outside of Ongoing Phase III Study
American CyroStem Warned by FDA to Stop Using Stem Cell Therapy Without Approval and to Correct Safety Issues
Celixir’s cell therapy gets green light for heart failure trial
Medical Devices
Intarcia Therapeutics Secures Additional $206M Financing; Gates Foundation to Invest up to $140M in Grants and Equity
Bionic Pancreas System Successfully Controls Blood Sugar Without Risk of Hypoglycemia
Journal Papers
‘Decorated’ Stem Cells Could Offer Targeted Heart Repair
Stem cell biologist at Harvard retracts diabetes breakthrough manuscript published in Cell citing reproducibility issues
PharmaCyte Biotech’s Cannabinoid Therapy May Offer Potential for Childhood Brain Cancers
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche
Business
Cell Therapy
Clinical Trials
Events
Gene Therapy
Health
Immunotherapy
Intellectual Property
Journal Papers
Manufacturing
Medical Devices
New Products
People and Career
Pharma
Technology
Video
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Thermo Fisher Scientific Acquires MTI-GlobalStem
Cell Tribune
-
December 26, 2016
0
Pluristem and New York Blood Center to Collaborate in Evaluating PLX-R18 as an...
Cell Tribune
-
December 27, 2016
0
ViaCyte to Present at Four Upcoming Healthcare Events
Cell Tribune
-
February 21, 2017
0
Twenty-two New Patents Are Added To ViaCyte’s Intellectual Property Portfolio
Cell Tribune
-
January 4, 2017
0
Helix BioPharma Corp. announces the signing of a non-binding letter of intent with...
Cell Tribune
-
December 23, 2016
0
Business
Home
Business
Business
Helix BioPharma Corp. announces the signing of a non-binding letter of...
Cell Tribune
-
December 23, 2016
0
Business
Roswell Park Cancer Institute announces spinoff immunotherapy company
Cell Tribune
-
February 4, 2017
0
Business
Thermo Fisher Scientific Acquires MTI-GlobalStem
Cell Tribune
-
December 26, 2016
0
Business
CAR-T cell therapy benefits limited to few patients because of ‘Insurance...
Cell Tribune
-
January 11, 2018
0
Business
GenCure Opens BioManufacturing Center for Large-Scale Production of Adult Stem Cells...
Cell Tribune
-
January 10, 2018
0
Business
MaxCyte, Washington University collaborate to develop next generation CAR-based cell therapies
Cell Tribune
-
December 22, 2016
0
Business
Affimed and MD Anderson Announce Clinical Immuno-Oncology Development Collaboration
Cell Tribune
-
January 4, 2017
0
Business
ViaCyte to Present at Four Upcoming Healthcare Events
Cell Tribune
-
February 21, 2017
0
Business
Twenty-two New Patents Are Added To ViaCyte’s Intellectual Property Portfolio
Cell Tribune
-
January 4, 2017
0
Business
Dynamk Capital Invests in FloDesign Sonics, a Game-Changer for Cell Therapy
Cell Tribune
-
January 10, 2018
0
1
2
Page 1 of 2
57
Followers
Follow
EDITOR PICKS
Stem Cell Therapy Trial at Sanford First of its Kind in U.S. For Shoulder...
Cell Tribune
-
January 4, 2017
Servier Appoints MaSTherCell For The Development Of Its CAR-T Cell Therapy Manufacturing Platform
Cell Tribune
-
January 24, 2017
Caladrius Biosciences Updates Status of Receipt of Funds for a Portion of Previously Announced...
Cell Tribune
-
January 8, 2017
Affimed and MD Anderson Announce Clinical Immuno-Oncology Development Collaboration
Cell Tribune
-
January 4, 2017
